RS
R Squared Portfolio holdings
AUM
$181M
This Quarter Return
+8.75%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$181M
AUM Growth
+$87.9M
(+94%)
Cap. Flow
+$84.7M
Cap. Flow
% of AUM
46.7%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
577
New
288
Increased
108
Reduced
61
Closed
119
Top Buys
| 1 |
McDonald's
MCD
|
$3.97M |
| 2 |
Kellanova
K
|
$3.14M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$2.19M |
| 4 |
Progressive
PGR
|
$2.11M |
| 5 |
Palantir
PLTR
|
$1.97M |
Top Sells
| 1 |
Frontier Communications
FYBR
|
$1.87M |
| 2 |
Hilton Worldwide
HLT
|
$1.58M |
| 3 |
Walt Disney
DIS
|
$1.37M |
| 4 |
Meta Platforms (Facebook)
META
|
$1.18M |
| 5 |
Autodesk
ADSK
|
$1.1M |
Sector Composition
| 1 | Technology | 19.47% |
| 2 | Financials | 17.88% |
| 3 | Healthcare | 13.23% |
| 4 | Industrials | 13.09% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sangamo Therapeutics
SGMO
$165M
| $28.4K | 0.02% |
+52,459
| New | +$28.4K |
|
427
Open Lending Corp
LPRO
$267M
| $28K | 0.02% |
+14,432
| New | +$28K |
|
428
Lexicon Pharmaceuticals
LXRX
$396M
| $28K | 0.02% |
+29,559
| New | +$28K |
|
429
Ironwood Pharmaceuticals
IRWD
$188M
| $27.8K | 0.02% |
38,765
+28,735
| +286% | +$20.6K |
|
430
BRC Inc
BRCC
$174M
| $27.6K | 0.02% |
+21,064
| New | +$27.6K |
|
431
FiscalNote
NOTE
$58.7M
| $26.6K | 0.01% |
+4,133
| New | +$26.6K |
|
432
Heron Therapeutics
HRTX
$201M
| $26.2K | 0.01% |
+12,648
| New | +$26.2K |
|
433
Black Diamond Therapeutics
BDTX
$167M
| $25.1K | 0.01% |
+10,139
| New | +$25.1K |
|
434
Olaplex Holdings
OLPX
$994M
| $25.1K | 0.01% |
+17,897
| New | +$25.1K |
|
435
Fractyl Health
GUTS
$65.4M
| $24.1K | 0.01% |
+14,900
| New | +$24.1K |
|
436
Precigen
PGEN
$1.3B
| $23.4K | 0.01% |
+16,470
| New | +$23.4K |
|
437
Clean Energy Fuels
CLNE
$546M
| $23.2K | 0.01% |
+11,904
| New | +$23.2K |
|
438
Companhia Siderúrgica Nacional
SID
$1.99B
| $22.9K | 0.01% |
+16,368
| New | +$22.9K |
|
439
MaxCyte
MXCT
$150M
| $22.5K | 0.01% |
+10,300
| New | +$22.5K |
|
440
GrafTech
EAF
$256M
| $21.2K | 0.01% |
+2,182
| New | +$21.2K |
|
441
Fossil Group
FOSL
$165M
| $19.9K | 0.01% |
+13,430
| New | +$19.9K |
|
442
Iovance Biotherapeutics
IOVA
$901M
| $19.5K | 0.01% |
+11,343
| New | +$19.5K |
|
443
Fortress Biotech
FBIO
$110M
| $18.9K | 0.01% |
+10,171
| New | +$18.9K |
|
444
Rackspace Technology
RXT
$335M
| $18.5K | 0.01% |
+14,420
| New | +$18.5K |
|
445
Neumora Therapeutics
NMRA
$272M
| $18.4K | 0.01% |
+25,063
| New | +$18.4K |
|
446
Kosmos Energy
KOS
$784M
| $17.8K | 0.01% |
+10,363
| New | +$17.8K |
|
447
Tilray
TLRY
$1.31B
| $17.5K | 0.01% |
+42,239
| New | +$17.5K |
|
448
TScan Therapeutics
TCRX
$108M
| $16.2K | 0.01% |
+11,181
| New | +$16.2K |
|
449
SmartRent
SMRT
$275M
| $16.2K | 0.01% |
+16,336
| New | +$16.2K |
|
450
Standard BioTools
LAB
$497M
| $15.5K | 0.01% |
+12,947
| New | +$15.5K |
|